Over the past decade, subcutaneous formulations of anticancer drugs—originally administered intravenously—have been ...

Apogee Therapeutics, Inc. targets atopic dermatitis with APG777, aiming to outperform Dupixent. Learn more about APGE stock ...

Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.

Merck's Q3 2025 results saw huge growth in Winrevair and Capvaxive sales. Check out why I maintain my Strong Buy rating on ...

For patients newly diagnosed with Crohn’s disease, initiating anti-TNF therapy early led to better outcomes and lower overall ...

The investment, which will expand Eli Lilly’s existing campus in Puerto Rico, is slated to create 100 new jobs, on top of ...

Rosnilimab acts as an agonist to stimulate PD-1, killing those cells with high PD-1 expression and pushing others into an ...

Holy Cross Health is adding to an already impressive list of heart and vascular care specialists with the announcement that clinical cardiac electrophysiologist Alexandra M. Sanchez, MD has joined the ...

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it ...

Johnson & Johnson (NYSE:JNJ) today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with ...

Panelists discuss how new dual-targeting agents and TKIs are redefining treatment approaches in EGFR-positive NSCLC.

As momentum for Biogen’s newer drugs for neurological disorders builds at a slow and steady pace, it appears that the company ...